These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Therapeutic applications of antisense oligonucleotides in asthma and allergy. Isidoro-García M, Dávila I. Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979 [Abstract] [Full Text] [Related]
13. The approach of triple helix formation in control of gene expression and the treatment of tumors expressing IGF-I. Upegui-Gonzalez LC, François JC, Ly A, Trojan J. Adv Exp Med Biol; 2000 Nov; 465():319-32. PubMed ID: 10810636 [No Abstract] [Full Text] [Related]
16. Antisense oligonucleotides as therapeutic agents. Alama A, Barbieri F, Cagnoli M, Schettini G. Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660 [Abstract] [Full Text] [Related]
17. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver? Kortylewski M, Nechaev S. Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948 [No Abstract] [Full Text] [Related]
18. Oligonucleotide treatment of ras-induced tumors in nude mice. Wickstrom E. Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698 [Abstract] [Full Text] [Related]
19. [Antisense oligonucleotides: a new therapeutic approach]. Guinot P, Temsamani J. Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897 [Abstract] [Full Text] [Related]